A randomized controlled trial evaluating the protective effect of a gonadotrophin-releasing hormone agonist on ovarian function in young women with Non-Hodgkin's Lymphoma receiving a 14 day regimen of rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP-14).
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Goserelin (Primary) ; Calcium; Norethisterone
- Indications Female infertility
- Focus Therapeutic Use
- 24 May 2012 Status changed from not yet recruiting to discontinued as reported by Australian New Zealand Clinical Trials Registry record.
- 05 Aug 2011 New trial record